Image

Global Point of Care Diagnostics Market – Industry Trends and Forecast to 2029

  • Healthcare
  • Upcoming Report
  • Jul 2022
  • Global
  • 350 Pages
  • No of Tables: 220
  • No of Figures: 60

Global Point of Care Diagnostics Market, By Platform (Lateral Flow Assays, Dipsticks, Microfluidics, Molecular Diagnostics, Immunoassays), Prescription (Prescription-Based Testing, OTC Testing), End-User (Professional Diagnostic Centers, Home Care, Research Laboratories, Other End Users), Product (Glucose, Cardio Metabolic, Infectious Disease, Influenza, HIV, Hepatitis C, Sexually Transmitted Disease (STD), Healthcare-Associated Infection (HAI), Respiratory Infection , Tropical Disease, Other Infectious Disease, Coagulation, PT/INR Activated Clotting Time (ACT/APTT), Pregnancy and Fertility, Tumor/Cancer Marker, Urinalysis, Cholesterol, Hematology, Drugs-of-Abuse, Fecal Occult, Other POC Products), – Industry Trends and Forecast to 2029

 

Point of Care Diagnostics Market

Market Analysis and Size

Point-of-care testing diagnostics have numerous advantages, allowing patients to be diagnosed in a variety of settings, including the doctor's office, an ambulance, the home, the field, or the hospital. The outcomes of care are timely and provide the patient with prompt treatment. Chronic diseases, such as diabetes, rheumatism, and cancer, are becoming more common around the world for a variety of reasons, including an increase in the geriatric population, sedentary lifestyles, unhealthy eating habits, and environmental factors. Chronic diseases, for example, kill more than 38 million people worldwide each year. Cardiovascular diseases cause the most chronic disease deaths each year, killing 17.5 million people, followed by cancer (8.2 million), respiratory diseases (4 million), and diabetes (1.5 million).

Data Bridge Market Research analyses that the point of care diagnostics market is expected to reach the value of USD 68.21 billion by the year 2029, at a CAGR of 9.1% during the forecast period. The rising prevalence of infectious diseases in developing countries is propelling the point-of-care diagnostics market.

Market Definition

Point-of-Care diagnostics are techniques used to make an early and accurate diagnosis of a disease. These techniques are highly sensitive, cost-effective, and yield results in a short period of time. These techniques are used in hospitals, clinics, ambulatory care, home healthcare, and research laboratories.

Report Metric

Details

Forecast Period

2022 to 2029

Base Year

2021

Historic Years

2020 (Customizable to 2019 - 2014)

Quantitative Units

Revenue in USD Million, Volumes in Units, Pricing in USD

Segments Covered

By Platform (Lateral Flow Assays, Dipsticks, Microfluidics, Molecular Diagnostics, Immunoassays), Prescription (Prescription-Based Testing, OTC Testing), End-User (Professional Diagnostic Centers, Home Care, Research Laboratories, Other End Users), Product (Glucose, Cardio Metabolic, Infectious Disease, Influenza, HIV, Hepatitis C, Sexually Transmitted Disease (STD), Healthcare-Associated Infection (HAI), Respiratory Infection , Tropical Disease, Other Infectious Disease, Coagulation, PT/INR Activated Clotting Time (ACT/APTT), Pregnancy and Fertility, Tumor/Cancer Marker, Urinalysis, Cholesterol, Hematology, Drugs-of-Abuse, Fecal Occult, Other POC Products)

Countries Covered

U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

Market Players Covered

Abbott(US), Siemens Healthineers AG (Germany), Quidel Corporation (US), F. Hoffman-La Roche Ltd. (Switzerland), Danaher Corporation (US), Becton, Dickinson and Company (US), Chembio Diagnostics (US), EKF Diagnostics (UK), Trinity Biotech plc (Ireland), Instrumentation Laboratory (a Werfen Company) (US), Nova Biomedical (US), PTS Diagnostics (US), Sekisui Diagnostics (US), Thermo Fisher Scientific (US), bioMérieux S.A. (France).Takeda Pharmaceutical Company Limited., Pfizer Inc., Biogen, CSL, Bayer AG, Grifols, S.A., Sun Pharmaceutical Industries Ltd., Octapharma AG, Ferring B.V., Novo Nordisk A/S, Alnylam Pharmaceuticals, Inc., Xenetic Biosciences, Inc., Bristol-Myers Squibb Company, Sanofi, Janssen Pharmaceuticals, Inc., Amgen Inc., Cangene Corporation, BD, Bosch Healthcare Solutions GmbH, Baxter and Novartis AG

 

Opportunities

  1. incidence of target conditions
  2. government support
  3. number of clia-waived POC tests

 

  • Rising incidence of target conditions
  • Rising government support
  • Rising number of clia-waived POC tests

 

 

Point of Care Diagnostics Market Dynamics

Drivers

  • The rise in the cases of chronic diseases

Rising incidence of target conditions, rising government support, rising number of clia-waived POC tests, rising healthcare expenditures globally, rising technological advancements and adoption of home-based point of care devices, and rising initiatives implemented by government and not-for-profit associations for raising health awareness are the major factors driving the point-of-care diagnostics market, among others

The increase in adoption of latest technologies and growing awareness

Rising technological advancements is the vital factor escalating the market growth, also increasing ising awareness via conferences and events, rising POC tests with multiplexing capabilities, healthcare decentralisation, and emerging markets will create new opportunities for the point-of-care diagnostics market during the forecasted period.

  • Regulatory Compliance

Maintaining compliance with medical reforms and regulations raises the demand for these solutions. The increase in the funding by the federal government to drive the adoption of these solutions further influence the market. Additionally, the surge in healthcare expenditure, advancements in healthcare infrastructure, and high demand for expanded care delivery positively affect the point of care diagnostics market.

Opportunities

Increasing personalised medicine, mass cytometry development, and the combination of cell- and bead-based flow cytometry technologies, improving healthcare infrastructure in emerging markets, and the rise of miniaturised and technologically advanced devices will all create new opportunities for the point of care diagnostics market.

Restraints/Challenges

Rising pricing pressure due to reimbursement cuts and budget constraints, as well as rising stringent and time-consuming regulatory policies, will obstruct market growth, while lack of alignment with definitive central lab methods, insufficient knowledge about the use of POC devices in professional settings, and reluctance to change existing diagnostic practises, will further challenge the growth of the point-of-care diagnostics market.

This point of care diagnostics market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the point of care diagnostics market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

COVID-19 Impact on Point of Care Diagnostics Market

The COVID-19 outbreak has accelerated the global demand for diagnostic kits to detect the disease quickly. However, countries all over the world are suffering from a severe lack of laboratory-based molecular assays. As a result, many players are focusing on increasing the supply of tests globally. The point-of-care diagnostics market will expand significantly in 2022, owing to the increased use of POC tests that can quickly diagnose COVID-19. Because of the need for quick diagnostic results, point-of-care testing has become an essential diagnostic tool. The rapidly increasing number of COVID-19 cases, as well as the growing pressure on governments to improve patient management, have increased demand for rapid antigen testing kits that can be used effectively in point-of-care settings.

Recent Development

  • Roche will launch its Cobas Pulse System in select countries that accept the CE Mark in January 2022. This is the latest generation of connected point-of-care solutions for professional blood glucose management from Roche Diagnostics.
  • Thermo Fisher Scientific announced in October 2021 that it had received FDA Emergency Use Authorization (EUA) to run COVID-19 tests from a new saliva sample collection method using the Spectrum Solutions SpectrumDNA SDNA-1000 collection device, a high-throughput, automated COVID-19 testing system on the Amplitude Solution.
  • BioMérieux and Specific Diagnostics announced a co-exclusive distribution agreement in Europe for the SPECIFIC REVEAL Rapid AST system in June 2021. The system is an ideal companion to bioMérieux's BIOFIRE BCID2.

Global Point of Care Diagnostics Market Scope

The point of care diagnostics market is segmented on the basis of type, application and end-uplatform, prescription, end-user, and productser. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Platform

  • Lateral flow assays
  • Dipsticks
  • Microfluidics
  • Molecular diagnostics
  • Immunoassays
  • Others

On the basis of platform, point-of-care diagnostics market is segmented into lateral flow assays, dipsticks, microfluidics, molecular diagnostics and immunoassays.

Prescription

  • Prescription Based
  • OTC testing

Based on prescription, the point-of-care diagnostics market is segmented into prescription-based testing and OTC testing.

End User

  • Professional diagnostic centers
  • Research laboratories
  • Home care
  • Others

Based on end-user, the point-of-care diagnostics market is segmented into professional diagnostic centers, home care, research laboratories and other end users. Professional diagnostic centers have been further segmented into clinical laboratories, outpatient healthcare & ambulatory care settings and hospitals/critical care centers.

Product

  • Glucose
  • Cardio metabolic
  • Infectious disease
  • Influenza
  • Hiv
  • Hepatitis c
  • Sexually transmitted disease (std)
  • Healthcare-associated infection (hai)
  • Respiratory infection
  • Tropical disease
  • Other infectious disease
  • Coagulation, pt/inr activated clotting time (act/aptt)
  • Pregnancy and fertility
  • Tumor/cancer marker
  • Urinalysis
  • Cholesterol
  • Hematology
  • Drugs-of-abuse
  • Fecal occult
  • Other poc products

The point-of-care diagnostics market is also segmented on the basis of product into glucose, cardio metabolic, infectious disease, influenza, HIV, hepatitis C, sexually transmitted disease (STD), healthcare-associated infection (HAI), respiratory infection, tropical disease, other infectious disease, coagulation, PT/INR activated clotting time (ACT/APTT), pregnancy and fertility, tumor/cancer marker, urinalysis, cholesterol, hematology, drugs-of-abuse, fecal occult and other POC products. Glucose monitoring products have been further segmented into strips, meters, lancets and lancing device. Cardiometabolic has been further segmented into cardiac marker, blood gas/electrolytes and HBA1C.

Point of Care Diagnostics Market Regional Analysis/Insights

The point of care diagnostics market is analysed and market size insights and trends are provided by country, platform, prescription, end-user, and product as referenced above.

The countries covered in the point of care diagnostics market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America dominates the point-of-care diagnostics market due to the growing presence of supportive government bodies that promote point-of-care diagnostics or testing in this region. Asia-Pacific is expected to be the fastest growing region in terms of growth in the point-of-care diagnostics market, owing to rising constant developments by international and local players to meet an untapped market need in this region.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.   

Healthcare Infrastructure growth Installed base and New Technology Penetration

The point of care diagnostics market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for point of care diagnostics market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the point of care diagnostics market. The data is available for historic period 2010-2020.

Competitive Landscape and Point of Care Diagnostics Market Share Analysis

The point of care diagnostics market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to point of care diagnostics market.

Some of the major players operating in the point of care diagnostics market are

  • Abbott Laboratories (US)
  • Siemens Healthineers AG (Germany)
  • Quidel Corporation (US)
  • F. Hoffman-La Roche Ltd. (Switzerland)
  • Danaher Corporation (US)
  • Becton, Dickinson and Company (US)
  • Chembio Diagnostics (US)
  • EKF Diagnostics (UK)
  • Trinity Biotech plc (Ireland)
  • Instrumentation Laboratory (a Werfen Company) (US)
  • Nova Biomedical (US)
  • PTS Diagnostics (US)
  • Sekisui Diagnostics (US)
  • Thermo Fisher Scientific (US)
  • bioMérieux S.A. (France).

Research Methodology: Global Point of Care Diagnostics Market

Data collection and base year analysis is done using data collection modules with large sample sizes. The market data is analyzed and estimated using market statistical and coherent models. Also market share analysis and key trend analysis are the major success factors in the market report. To know more please request an analyst call or can drop down your inquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market, and primary (industry expert) validation. Apart from this, data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

Customization Available

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Factbook) or can assist you in creating presentations from the data sets available in the report.


SKU-

Please fill in the below form for detailed Table of Content

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Table

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Figure

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

CHOOSE LICENCE TYPE
  • 7000.00
  • 4800.00
  • 3000.00
  • 8000.00
  • 12000.00
Why Choose Us
Unlocking New Opportunities on this Report Post Covid-19

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions



Frequently Asked Questions

The current market value for point of care diagnostics market is generated 68.21 billion USD forecasted till 2029.
The Point of Care Diagnostics Market is to grow at a CAGR of 9.1% during the forecast by 2029.
On the basis of product, the Point of Care Diagnostics Market is segmented into Glucose, Cardio Metabolic, Infectious Disease, Influenza, HIV, Hepatitis C, Sexually Transmitted Disease (STD), Healthcare-Associated Infection (HAI), Respiratory Infection , Tropical Disease, Other Infectious Disease, Coagulation, PT/INR Activated Clotting Time (ACT/APTT), Pregnancy and Fertility, Tumor/Cancer Marker, Urinalysis, Cholesterol, Hematology, Drugs-of-Abuse, Fecal Occult, Other POC Products.
The major players operating in the Point of Care Diagnostics Market are Abbott(US), Siemens Healthineers AG (Germany), Quidel Corporation (US), F. Hoffman-La Roche Ltd. (Switzerland), Danaher Corporation (US), Becton, Dickinson and Company (US), Chembio Diagnostics (US), EKF Diagnostics (UK), Trinity Biotech plc (Ireland), Instrumentation Laboratory (a Werfen Company) (US), Nova Biomedical (US), PTS Diagnostics (US), Sekisui Diagnostics (US), Thermo Fisher Scientific (US), bioMérieux S.A.